Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology

Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership Technicals

Ticker	Company	Exchange	Industry	Market Cap	Price	1d %	EBITDA	P/E	D/E
CORT	CORCEPT THERAPEUTICS INC	NASDAQ	Biotechnology	$2.82B	$27.04	1.65%	$122.89M	23.51x	0.20
INCY	INCYTE CORP	NASDAQ	Biotechnology	$11.91B	$53.06	-0.82%	$1.11B	15.93x	0.32
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	NASDAQ	Biotechnology	$1.71B	$30.14	-3.64%	$237.47M	12.83x	0.64
PBYI	PUMA BIOTECHNOLOGY INC	NASDAQ	Biotechnology	$232.03M	$4.81	0.42%	$41.45M	14.58x	3.20
BMRN	BIOMARIN PHARMACEUTICAL INC	NASDAQ	Biotechnology	$15.39B	$81.03	-0.84%	$359.85M	74.34x	0.36
VYGR	VOYAGER THERAPEUTICS INC	NASDAQ	Biotechnology	$458.30M	$8.44	0.00%	$126.46M	2.74x	0.49
HALO	HALOZYME THERAPEUTICS INC	NASDAQ	Biotechnology	$5.49B	$43.15	-1.57%	$495.45M	17.61x	9.36
UTHR	UNITED THERAPEUTICS CORP	NASDAQ	Biotechnology	$11.72B	$264.27	-0.67%	$1.49B	11.82x	0.22
EXEL	EXELIXIS INC	NASDAQ	Biotechnology	$6.22B	$21.37	-1.79%	$312.76M	33.39x	0.32
GMAB	GENMAB A	NASDAQ	Biotechnology	$19.07B	$28.84	0.10%	N/A	24.01x	0.13
ROIV	ROIVANT SCIENCES LTD	NASDAQ	Biotechnology	$8.97B	$11.13	-1.07%	$4.58B	2.00x	0.12
VRTX	VERTEX PHARMACEUTICALS INC	NASDAQ	Biotechnology	$109.10B	$422.78	0.90%	$5.01B	27.14x	0.29
MEIP	MEI PHARMA INC	NASDAQ	Biotechnology	$20.12M	$3.02	-1.63%	$28.01M	0.77x	0.40
TGTX	TG THERAPEUTICS INC	NASDAQ	Biotechnology	$2.57B	$16.62	-1.77%	$53.85M	57.31x	1.33
CPRX	CATALYST PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.88B	$15.94	1.85%	$122.26M	26.57x	0.15
LPCN	LIPOCINE INC	NASDAQ	Biotechnology	$28.45M	$5.32	1.53%	-$8.94M	-3.13x	0.06
REGN	REGENERON PHARMACEUTICALS INC	NASDAQ	Biotechnology	$107.30B	$973.80	0.60%	$4.55B	26.96x	0.27
RPRX	ROYALTY PHARMA PLC	NASDAQ	Biotechnology	$16.78B	$28.09	0.43%	$983.33M	15.69x	0.64
AVRO	AVROBIO INC	NASDAQ	Biotechnology	$55.22M	$1.23	-1.60%	$30.44M	1.76x	0.04
PTGX	PROTAGONIST THERAPEUTICS INC	NASDAQ	Biotechnology	$1.66B	$28.23	-0.14%	$168.74M	10.57x	0.12
MDXG	MIMEDX GROUP INC	NASDAQ	Biotechnology	$1.10B	$7.45	2.90%	$50.76M	14.33x	0.42
LGND	LIGAND PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.57B	$87.28	1.35%	$158.80M	16.01x	0.13
SRPT	SAREPTA THERAPEUTICS INC	NASDAQ	Biotechnology	$12.46B	$131.82	-0.36%	$91.13M	321.51x	2.36
BNOX	BIONOMICS LIMITED	NASDAQ	Biotechnology	$10.98M	$0.95	-1.25%	N/A	0.03x	0.34
SPRO	SPERO THERAPEUTICS INC	NASDAQ	Biotechnology	$88.35M	$1.64	-2.96%	$25.77M	3.81x	0.71
CRSP	CRISPR THERAPEUTICS AG	NASDAQ	Biotechnology	$4.35B	$51.17	-4.44%	-$195.23M	-19.02x	0.17
OCUP	OCUPHIRE PHARMA INC	NASDAQ	Biotechnology	$44.59M	$1.72	-12.24%	-$11.28M	-3.58x	0.13
TFFP	TFF PHARMACEUTICALS INC	NASDAQ	Biotechnology	$4.91M	$1.95	-10.55%	-$20.74M	-0.16x	0.26
KNSA	KINIKSA PHARMACEUTICALS LTD	NASDAQ	Biotechnology	$1.39B	$19.53	-3.27%	-$16.36M	162.75x	0.20
PRTA	PROTHENA CORP PUBLIC LTD CO	NASDAQ	Biotechnology	$1.15B	$21.34	-3.00%	-$177.60M	-6.63x	0.24
IMMP	IMMUTEP LTD	NASDAQ	Biotechnology	$342.38M	$2.88	-4.32%	N/A	-11.29x	0.07
JAZZ	JAZZ PHARMACEUTICALS PLC	NASDAQ	Biotechnology	$6.91B	$109.63	-3.09%	$1.16B	20.96x	2.06
VYNE	VYNE THERAPEUTICS INC	NASDAQ	Biotechnology	$38.79M	$2.67	0.75%	-$29.08M	-2.21x	0.10
OCUL	OCULAR THERAPEUTIX INC	NASDAQ	Biotechnology	$876.67M	$5.66	-3.08%	-$98.23M	-5.10x	0.32
VTGN	VISTAGEN THERAPEUTICS INC	NASDAQ	Biotechnology	$118.10M	$4.37	-2.46%	-$31.51M	-1.27x	0.06
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	NASDAQ	Biotechnology	$75.91M	$6.63	-1.81%	-$6.41M	-10.69x	0.20
INM	INMED PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.59M	$0.26	-4.01%	-$5.75M	-0.21x	0.19
MDWD	MEDIWOUND LTD	NASDAQ	Biotechnology	$159.72M	$17.32	-2.20%	-$3.34M	-23.09x	1.10
GNFT	GENFIT SA	NASDAQ	Biotechnology	$187.38M	$3.76	0.53%	-$23.09M	-5.97x	1.56
ADAG	ADAGENE INC	NASDAQ	Biotechnology	$98.38M	$2.23	5.19%	-$14.94M	-5.10x	0.64
JANX	JANUX THERAPEUTICS INC	NASDAQ	Biotechnology	$2.54B	$48.92	-5.81%	-$53.56M	-40.43x	0.05
KZR	KEZAR LIFE SCIENCES INC	NASDAQ	Biotechnology	$56.28M	$0.77	-5.39%	-$98.68M	-0.55x	0.18
MIRM	MIRUM PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.17B	$24.76	-4.14%	-$127.08M	-6.57x	1.78
QSI	QUANTUM-SI INC	NASDAQ	Biotechnology	$241.09M	$1.70	-7.10%	-$85.96M	-2.62x	0.09
ZLAB	ZAI LAB LTD	NASDAQ	Biotechnology	$1.99B	$20.08	-4.43%	-$321.14M	-5.74x	0.30
XCUR	EXICURE INC	NASDAQ	Biotechnology	$3.94M	$0.46	-1.72%	$5.04M	0.27x	0.81
PLX	PROTALIX BIOTHERAPEUTICS INC	NYSEMKT	Biotechnology	$80.65M	$1.10	-12.00%	$9.65M	11.00x	2.02
FULC	FULCRUM THERAPEUTICS INC	NASDAQ	Biotechnology	$462.66M	$7.47	-0.40%	-$95.16M	-4.70x	0.10
LEGN	LEGEND BIOTECH CORP	NASDAQ	Biotechnology	$7.87B	$43.24	-5.01%	-$477.87M	-14.71x	0.48
ANIX	ANIXA BIOSCIENCES INC	NASDAQ	Biotechnology	$95.70M	$3.00	4.53%	-$10.70M	-8.82x	0.07
NVO	NOVO NORDISK A S	NYSE	Biotechnology	$579.17B	$128.42	-0.19%	$17.67B	44.70x	2.02
AGIO	AGIOS PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.87B	$33.00	0.24%	-$335.52M	-5.22x	0.14
TECH	BIO-TECHNE CORP	NASDAQ	Biotechnology	$12.75B	$80.91	1.61%	$354.14M	63.71x	0.35
VRDN	VIRIDIAN THERAPEUTICS INC	NASDAQ	Biotechnology	$887.13M	$13.90	-0.07%	-$215.27M	-3.10x	0.08
ZYME	ZYMEWORKS INC	NASDAQ	Biotechnology	$622.91M	$8.81	-4.55%	-$111.14M	-4.95x	0.26
XBIO	XENETIC BIOSCIENCES INC	NASDAQ	Biotechnology	$6.00M	$3.90	-3.61%	-$4.47M	-1.33x	0.08
KPRX	KIORA PHARMACEUTICALS INC	NASDAQ	Biotechnology	$12.76M	$0.49	0.21%	$2.95M	-0.43x	0.22
SEER	SEER INC	NASDAQ	Biotechnology	$129.55M	$2.00	-3.16%	-$76.99M	-1.53x	0.10
SLGL	SOL-GEL TECHNOLOGIES LTD	NASDAQ	Biotechnology	$19.44M	$0.70	-6.31%	-$26.90M	-0.69x	0.17
TRDA	ENTRADA THERAPEUTICS INC	NASDAQ	Biotechnology	$484.10M	$14.34	-0.14%	$43.74M	20.49x	0.90
RNA	AVIDITY BIOSCIENCES INC	NASDAQ	Biotechnology	$2.48B	$25.96	-4.21%	-$223.21M	-8.77x	0.15
ORMP	ORAMED PHARMACEUTICALS INC	NASDAQ	Biotechnology	$97.31M	$2.40	0.63%	$9.81M	9.21x	0.23
MNKD	MANNKIND CORP	NASDAQ	Biotechnology	$1.18B	$4.32	0.23%	$45.65M	108.00x	-3.09
ACIU	AC IMMUNE SA	NASDAQ	Biotechnology	$229.15M	$2.31	-1.70%	-$58.90M	-3.18x	0.14
DNTH	DIANTHUS THERAPEUTICS INC	NASDAQ	Biotechnology	$712.90M	$24.29	-2.57%	-$43.10M	6.34x	0.03
ARGX	ARGENX SE	NASDAQ	Biotechnology	$22.18B	$374.63	-2.07%	-$209.00M	-66.79x	0.11
VNDA	VANDA PHARMACEUTICALS INC	NASDAQ	Biotechnology	$293.32M	$5.04	0.60%	$711.00k	-56.00x	0.20
TRAW	TRAWS PHARMA INC	NASDAQ	Biotechnology	$13.59M	$0.65	-0.46%	-$18.93M	-0.72x	1.13
DBVT	DBV TECHNOLOGIES SA	NASDAQ	Biotechnology	$111.09M	$0.58	0.88%	-$93.17M	-1.40x	0.31
TARS	TARSUS PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.40B	$37.00	8.70%	-$143.00M	-7.82x	0.27
CUE	CUE BIOPHARMA INC	NASDAQ	Biotechnology	$84.64M	$1.74	-9.14%	-$44.60M	-1.63x	0.80
MRKR	MARKER THERAPEUTICS INC	NASDAQ	Biotechnology	$36.77M	$4.13	-2.36%	-$8.23M	-4.39x	0.22
IDYA	IDEAYA BIOSCIENCES INC	NASDAQ	Biotechnology	$3.12B	$41.17	1.30%	-$124.76M	-20.48x	0.03
ALT	ALTIMMUNE INC	NASDAQ	Biotechnology	$511.91M	$7.22	-6.48%	-$91.79M	-4.48x	0.09
GLYC	GLYCOMIMETICS INC	NASDAQ	Biotechnology	$17.21M	$0.27	-10.40%	-$36.35M	-0.46x	0.18
SPRB	SPRUCE BIOSCIENCES INC	NASDAQ	Biotechnology	$34.28M	$0.83	-0.60%	-$47.14M	-0.67x	0.36
BGNE	BEIGENE LTD	NASDAQ	Biotechnology	$16.87B	$161.13	-4.45%	-$713.52M	-277.81x	0.69
CALT	CALLIDITAS THERAPEUTICS AB	NASDAQ	Biotechnology	$611.89M	$20.54	1.03%	-$31.50M	-12.86x	4.55
ACLX	ARCELLX INC	NASDAQ	Biotechnology	$2.66B	$49.74	-5.67%	-$22.77M	-48.29x	0.57
CHRS	COHERUS BIOSCIENCES INC	NASDAQ	Biotechnology	$217.98M	$1.90	-10.38%	-$10.90M	-2.60x	-10.33
BRNS	BARINTHUS BIOTHERAPEUTICS PLC	NASDAQ	Biotechnology	$90.88M	$2.34	-0.64%	-$69.64M	-1.22x	0.15
FATE	FATE THERAPEUTICS INC	NASDAQ	Biotechnology	$464.43M	$4.08	4.62%	-$171.14M	-2.13x	0.34
CMRX	CHIMERIX INC	NASDAQ	Biotechnology	$87.03M	$0.97	-3.86%	-$82.60M	-1.03x	0.12
MREO	MEREO BIOPHARMA GROUP PLC	NASDAQ	Biotechnology	$424.98M	$3.03	-7.34%	-$27.34M	-15.15x	0.32
APRE	APREA THERAPEUTICS INC	NASDAQ	Biotechnology	$30.35M	$5.59	1.64%	-$15.50M	-1.42x	0.34
LXRX	LEXICON PHARMACEUTICALS INC	NASDAQ	Biotechnology	$440.76M	$1.79	-5.29%	-$176.77M	-2.16x	0.44
SAGE	SAGE THERAPEUTICS INC	NASDAQ	Biotechnology	$716.17M	$11.90	-3.57%	-$501.74M	-1.42x	0.09
ZNTL	ZENTALIS PHARMACEUTICALS INC	NASDAQ	Biotechnology	$890.51M	$12.54	0.16%	-$218.17M	-3.77x	0.22
XOMA	XOMA CORP	NASDAQ	Biotechnology	$296.08M	$25.44	7.39%	-$34.73M	-6.49x	1.67
CRNX	CRINETICS PHARMACEUTICALS INC	NASDAQ	Biotechnology	$3.79B	$48.00	-2.87%	-$232.29M	-12.77x	0.12
KRRO	KORRO BIO INC	NASDAQ	Biotechnology	$409.12M	$51.00	-7.07%	-$73.91M	-0.96x	0.31
YMAB	Y-MABS THERAPEUTICS INC	NASDAQ	Biotechnology	$538.88M	$12.28	-4.58%	-$24.37M	-25.06x	0.24
IMTX	IMMATICS NV	NASDAQ	Biotechnology	$916.84M	$10.83	1.79%	-$97.57M	-8.31x	1.27
ACAD	ACADIA PHARMACEUTICALS INC	NASDAQ	Biotechnology	$2.52B	$15.25	0.26%	$25.56M	-1,525.00x	0.84
MESO	MESOBLAST LTD	NASDAQ	Biotechnology	$746.89M	$7.36	2.65%	N/A	-8.07x	0.32
MOLN	MOLECULAR PARTNERS AG	NASDAQ	Biotechnology	$124.85M	$3.80	2.67%	-$61.83M	-1.77x	0.12
ARVN	ARVINAS INC	NASDAQ	Biotechnology	$2.15B	$31.44	-1.60%	-$346.70M	-5.20x	0.99
ATAI	ATAI LIFE SCIENCES NV	NASDAQ	Biotechnology	$313.79M	$1.89	-7.80%	-$35.85M	-7.56x	0.20
AUPH	AURINIA PHARMACEUTICALS INC	NASDAQ	Biotechnology	$717.96M	$5.02	-2.90%	-$41.87M	-11.95x	0.44
ALGS	ALIGOS THERAPEUTICS INC	NASDAQ	Biotechnology	$57.02M	$0.73	-5.93%	-$83.36M	-0.70x	1.14

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the top biotech stock with a Zen Score of 67, which is 44 points higher than the biotech industry average of 23. It passed 22 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 12.67% over the past year, overperforming other biotech stocks by 34 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 50.4% from Corcept Therapeutics's current stock price of $27.04.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the second best biotech stock with a Zen Score of 64, which is 41 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -16.99% over the past year, overperforming other biotech stocks by 4 percentage points.

Incyte has an average 1 year price target of $74.92, an upside of 41.2% from Incyte's current stock price of $53.06.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 30.77% have issued a Strong Buy rating, 23.08% have issued a Buy, 46.15% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the third best biotech stock with a Zen Score of 62, which is 39 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -15.81% over the past year, overperforming other biotech stocks by 5 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $39.80, an upside of 32.05% from Harmony Biosciences Holdings's current stock price of $30.14.

Harmony Biosciences Holdings stock has a consensus Hold recommendation according to Wall Street analysts. Of the 5 analysts covering Harmony Biosciences Holdings, 40% have issued a Strong Buy rating, 20% have issued a Buy, 0% have issued a hold, while 20% have issued a Sell rating, and 20% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 3 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.95%, which is 43 percentage points higher than the biotech industry average of 15.21%.

Mei Pharma's dividend payout ratio of 44.6% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk A S (NYSE:NVO)

Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.07%, which is -14 percentage points lower than the biotech industry average of 15.21%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% eight times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 47.8% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)

Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.4%, which is -15 percentage points lower than the biotech industry average of 15.21%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 25.2% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -1.62% in the last day, and down -2.51% over the last week. Macrogenics was the among the top losers in the biotechnology industry, dropping -77.44% yesterday.

MacroGenics shares are trading lower after the company reported worse-than-expected Q1 financial results.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -16.99% in the past year. It has overperformed other stocks in the biotech industry by 4 percentage points.

2. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -17.04% in the past year. It has overperformed other stocks in the biotech industry by 4 percentage points.

3. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Corcept Therapeutics has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Corcept Therapeutics's stock has gained 12.67% in the past year. It has overperformed other stocks in the biotech industry by 34 percentage points.

Are biotech stocks a good buy now?

50% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 84.9% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 6.42x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.